Prices to rise for over 2,000 Japanese food items in July
Shoppers in Japan are facing yet another expensive month at the supermarket.
A survey has found that food and beverage makers plan to hike prices on over 2,000 items in July.
Private research firm Teikoku Databank says it polled 195 domestic companies.
It says prices will rise on 2,105 products in July. That's about five times the figure for the same month last year.
Seasonings will be the most heavily affected group, with 1,445 items in line for price hikes. This category includes spices and broth products.
206 alcohol and beverage items will also have their prices raised. The cost of confections, such as gum and chocolate, and processed foods including pre-cooked rice and pasta sauces will rise as well.
The research firm cites surging material prices and higher production costs as contributing factors.
Teikoku Databank expects hikes for more than 18,500 items by November. That would be nearly 50 percent more than the total for 2024.
The firm says the trend is likely to continue for some time, owing to supply instability amid abnormal weather conditions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NHK
32 minutes ago
- NHK
Japan's top trade negotiator vows not to sacrifice farming in Japan-US talks
Japan's top trade negotiator has reiterated his stance that the country will not seek a trade agreement with the United States in which Japan's farming industry is sacrificed. At a news conference on Tuesday, Economic Revitalization Minister Akazawa Ryosei was asked about a social media post by US President Donald Trump. The post in question read that Japan "won't take our RICE, and yet they have a massive rice shortage." Akazawa said agriculture forms the foundation of the nation. He said it is an extremely important task for the government and the ruling coalition to create an environment where farmers feel secure and can continue their work. He said both Japanese and US teams have continued sincere discussions toward a potential deal, but still remain at odds on some points and are yet to reach an agreement as a package. Akazawa said he hopes to work vigorously toward a deal that is beneficial to both sides, while protecting Japan's interests.
NHK
2 hours ago
- NHK
Sources: Japan to post record-high tax revenue for 5th year
Sources say that Japan's tax collectors brought in a record amount of revenue for the fifth consecutive year. Contributing factors include healthy bottom lines at corporations and higher consumption-tax proceeds due to inflation. The Finance Ministry estimates that total tax revenue for fiscal 2024 that ended in March topped 75 trillion yen, or 522 billion dollars. The figure would be at least 1.6 trillion yen more than a projection last November when a supplementary budget was being compiled. The ministry plans to announce the official results as early as this week.
Japan Times
2 hours ago
- Japan Times
Medipal seeks to diversify amid falling drug margins
Japan's largest drug wholesaler Medipal Holdings is seeking merger and acquisition opportunities to diversify its business and counter slower growth in the market. The distributor, which also sells cosmetics and sundries, is seeking to boost profit, excluding extraordinary items, to ¥100 billion ($694 million) by March 2027 from ¥65 billion in the latest fiscal year. "To do so, we need growth outside of organic means, including M&A,' Toshihide Yoda, senior managing director of Medipal Holdings said in an interview Monday. Medipal is expanding into areas such as animal health products and drug development as margins from selling pharmaceuticals gets squeezed in its home market. In Japan, the government is cutting the prices of novel drugs to cut costs to care for the aging population and encourage patients to use cheaper generic medicines. The company has committed to investing a total of ¥200 billion for growth and capital investment over five years through 2027. Medipal is budgeting around ¥10 billion to buy smaller regional wholesalers that supply drugs for animals, according to Yoda. The company, which holds about 22% stake in JCR Pharmaceutical in Japan, bought the rights to develop and sell four experimental treatments for rare diseases outside of Japan in 2022 and added another one in 2023. Shares of Medipal are down around 2% this year, while the benchmark Topix index has climbed 3%. Medipal disclosed its policy on the cost of capital for the first time in May and is seeking to boost its price-book-ratio above 1 by 2027, according to Yoda. The current ratio of 0.8, according to data compiled by Bloomberg. "We've focused on profit and loss and have been extremely insensitive to cost of capital until recently,' Yoda said. "But by setting the benchmark, we can now move toward the goal, constantly review and refine our targets.' The company has a 51% stake in a Japanese cosmetic wholesale Paltac. Medipal relied about half of its current profit on Paltac in 2022. Although the company is constantly discussing the parent-affiliate holding, it plans to keep its stake in Paltac as there's a high synergies between drugs and cosmetics wholesale businesses, according to Yoda. "We are the only company in the market that can supply everything that drug stores sell, from pharmaceuticals, to over-the-counter drugs and household goods,' which is a high-growth area, Yoda said. "So we'll have to think of tightening our relationships.' Japanese conglomerates are under pressure from regulators to streamline their corporate structures. In February, the Tokyo Stock Exchange cautioned companies with parent-affiliate listings to better protect minority shareholders' interests, stepping up its campaign to reduce such arrangements. Since then, NEC has acquired unit NEC Networks & System Integration, while the Toyota group plans to buy out and delist Toyota Industries. The move has fueled speculation that more companies may follow suit.
